13G Filing: Perceptive Advisors and Albireo Pharma Inc. (ALBO)

---

Item 1(a).

Name of Issuer:

Albireo Pharma, Inc. (the Issuer)

Item 1(b).

Address of Issuers Principal Executive Offices:

10 Post Office Square,
Suite 502 South

Boston, Massachusetts 02109

Item 2(a).

Names of Persons Filing:

The names of the persons filing this report
(collectively, the Reporting Persons) are:

Perceptive Advisors LLC (Perceptive Advisors)

Joseph Edelman (Mr. Edelman)

Perceptive Life Sciences Master Fund, Ltd. (the Master Fund)

Item 2(b).

Address of Principal Business Office or, if None, Residence:

The address of the
principal business office of each of the Reporting Persons is:

51 Astor Place, 10th Floor

New York, NY 10003

Item 2(c).

Citizenship:

Perceptive Advisors is a Delaware limited liability company

Mr. Edelman is a United States citizen

The Master Fund is a Cayman Islands corporation

Item 2(d).

Title of Class of Securities:

common stock, $0.01 par value per share
(Common Stock)

Item 2(e).

CUSIP Number:

01345P 10 6

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

Item 4.

Ownership.

The information required by this item with respect to each Reporting
Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G. The ownership percentages reported are based on 8,899,451 outstanding shares of Common Stock, as reported in the Issuers Form 10-Q filed on
November 14, 2017.